Key takeaways
Epzicom (abacavir/lamivudine) and Truvada (emtricitabine/tenofovir disoproxil fumarate) are both combination medications used to treat HIV, but they have some key differences. Epzicom is taken once daily and contains abacavir and lamivudine, both of which are nucleoside reverse transcriptase inhibitors (NRTIs). Truvada, also taken once daily, contains emtricitabine and tenofovir disoproxil fumarate, which are also NRTIs. Both are not a complete treatment for HIV and must be combined with another medication. One major difference is that Truvada is also approved for HIV PrEP (pre-exposure prophylaxis), while Epzicom is not. Epzicom requires a genetic test before use due to the risk of a severe allergic reaction, whereas Truvada does not. Additionally, Truvada can cause bone and kidney problems, which are less common with Epzicom. Both medications can worsen hepatitis B if stopped suddenly, but Truvada requires more frequent monitoring of kidney function. Both are available in generic forms, making them more affordable options.
